SDIC Fund Management
43
92M
37
2.87
21
0.14
6
- Stages of investment
- Areas of investment
Summary
In 2009 was created SDIC Fund Management, which is appeared as VC. The fund was located in Asia if to be more exact in China. The leading representative office of defined VC is situated in the Beijing.
We also calculated 2 valuable employees in our database.
The typical case for the fund is to invest in rounds with 3 participants. Despite the SDIC Fund Management, startups are often financed by Juren Capital, Intel Capital, Highlight Capital. The meaningful sponsors for the fund in investment in the same round are CMB International Capital Corporation, Matrix Partners China, Lilly Asia Ventures. In the next rounds fund is usually obtained by ZWC Partners, ShenZhen GTJA Investment Group, Rising Investments.
We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight United Imaging Healthcare, Ninebot, Banma Network Technologies. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Considering the real fund results, this VC is 71 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The usual things for fund are deals in the range of 50 - 100 millions dollars. The typical startup value when the investment from SDIC Fund Management is more than 1 billion dollars. The high activity for fund was in 2017. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this SDIC Fund Management performs on 20 percentage points less the average number of lead investments.
Investments analytics
Analytics
- Total investments
- 43
- Lead investments
- 21
- Exits
- 6
- Rounds per year
- 2.87
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (17)
- Manufacturing (14)
- Health Care (11)
- Biopharma (7)
- Automotive (6) Show 49 more
- Investments by region
-
- China (41)
- Japan (1)
- United States (1)
- Peak activity year
- 2017
- Number of Unicorns
- 5
- Number of Decacorns
- 5
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 398M
- Group Appearance index
- 0.81
- Avg. company exit year
- 31
- Avg. multiplicator
- 1.11
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Doma Biopharmaceutical | 02 Jun 2022 | Biotechnology | Early Stage Venture | 146M | Kagoshima, Kagoshima Prefecture, Japan |
Newcosemi Technology | 10 Apr 2024 | Late Stage Venture | Beijing, Beijing, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.